ClinicalTrials.gg
RecruitingNCT07441655FIGHT for LifeUpdated Aug 5, 2026

Families Implementing Good Health Traditions for Life

An interventional study of Families Implementing Good Health Traditions for Life in Diabetes, Chronic Disease and Type 2 Diabetes, sponsored by Morehouse School of Medicine. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-05.

Primary conditionDiabetes Mellitus, Type 2Registry: Diabetes MellitusReclassifiedWhy we changed it
Registry
Diabetes Mellitus — the first condition term the registry derived for this study.
ClinicalTrials.gg
Diabetes Mellitus, Type 2
Why
  1. The study's listed conditions name Diabetes Mellitus, Type 2, a narrower term within Diabetes Mellitus.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Morehouse School of Medicine · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study will provide evidence for the utility of using a community-engaged research approach to implement a tailored, family-oriented adaptation of the Diabetes Prevention Program that will have positive effects on risk factors associated with type 2 diabetes morbidity and mortality among Black families in a Southwest Georgia community.

Read the detailed description

The goal of this project is to utilize a community-engaged research approach to reduce type 2 diabetes risk among Black families through the tailoring of the diabetes prevention program for families. The proposed study will be carried out by researchers and community members with expertise in community engagement, type 2 diabetes prevention, and family interventions/programming. It is hypothesized that the Families Implementing Good Health Traditions for Life study (FIGHT for Life), a region specific adaptation of the Diabetes Prevention Program (DPP) for high-risk adults paired with a DPP-adapted curriculum for children will result in improved program acceptance and compliance, thus improving health indicators associated with type 2 diabetes risk across Black families. The efficacy of the community-engaged research-adapted FIGHT for Life intervention to improve weight, an important type 2 diabetes risk factor, in Black parents with pre-diabetes (primary outcome) will be evaluated. The goal is that parents enrolled in the family intervention will demonstrate a 4% reduction in weight at the end of the intervention.

02

Conditions studied

  • Diabetes
  • Chronic Disease
  • Type 2 Diabetes
  • Healthy Lifestyle
  • Nutrition, Healthy
  • Sedentary Behavior
  • Family
  • Family Research
  • Family and Household

Keywords

  • diabetes
  • rural
  • type 2 diabetes
  • nutrition
  • physical activity
  • diabetes prevention
  • family research
  • family and household
  • chronic disease
  • sedentary behavior
03

In context

Diabetes Mellitus, Type 2 Reclassified

10,371 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,406 are open to participants now.

This study's planned enrollment of 70 is below the median of 80 across 8,350 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Morehouse School of Medicine is the lead sponsor of 22 studies on the registry; 11 are open to participants now.

Compared within Diabetes Mellitus, Type 2, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Diabetes Mellitus. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Family 1.a.) Black Parent/Guardian: age 18 years or older residing in the same household with child (i.e., biological or have legal guardianship for child) 1.b.) Child: age 8-15 years old
  2. Parent/Guardian have level 5.7-6.4% (prediabetes)
  3. Parent/Guardian willing to commit to participation in a 20-month research study and have no plans to move from the area over the next 20-months
  4. Parent/child are ambulatory and able to participate in physical activity

Exclusion criteria

Exclusion Criteria:

  1. Individuals with severe psychological disorders that may prevent/interfere with study participation
  2. Physical impairments that may prevent participation in moderate intensity physical activity;
  3. Previous diagnosis of diabetes
  4. History of congestive heart failure, renal failure, or recent (\<12 months) cardiovascular events such as myocardial infarction or stroke;
  5. Person taking medications that may affect endpoint analyses
  6. Persons with co-morbid to physical activity or dietary changes.
  7. Currently pregnant or planning to become pregnant in the next year.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Other
    Families Implementing Good Health Traditions for Life

    Seven cohorts with a total of seventy families (10 families per cohort) will be enrolled in the study. Families will meet for weekly for 16 weeks and be administered child and adult specific curriculums to encourage healthy lifestyle changes. The adults will received the initial 16-week curriculum of the CDC's Diabetes Prevention Program, and the children will receive an aligned DPP-adapted curriculum.

    Behavioral: Families Implementing Good Health Traditions for Life

Interventions

  • BehavioralFamilies Implementing Good Health Traditions for Life

    The 16-session weekly curriculum will have five components: 1) strategies for monitoring food intake and reducing calories; 2) identifying and controlling both personal and social cues for unhealthy eating behaviors; 3) the role of stress in unhealthy eating and relapse prevention; 4) strategies for monitoring and improving physical activity and sedentary behaviors; and 5) strategies to improve family support and cohesion. Parents and children will be divided into separate, 2-hour sessions most weeks. The sessions will be co-facilitated by trained CHWs and research staff members. As children of different ages will be participating, enough staff will be present to keep youth sessions well-coordinated in order to engage all ages. All sessions will be held in community locations convenient to the families, such as YMCAs, faith-based institutions, federally qualified health centers, etc.

    Also known as: FIGHT of Life

06

What researchers measure

Primary outcomes

  1. Change in weight from baseline to post-intervention at 4 months

    Parents enrolled in the family intervention will demonstrate a 4% change in weight at the end of the intervention.

    Time frame: 4 months

07

Study locations

1 of 1 sites recruiting
  • Morehouse School of Medicine
    Albany, Georgia 31705, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual Participant Data (IPD) collected during this study will not be shared with external researchers. The decision not to share IPD is based on considerations including participant confidentiality, informed consent limitations, and institutional data protection policies. All data will be reported in aggregate form in publications and presentations to ensure that no individual participant can be identified. Qualified researchers may contact the study sponsor or principal investigator with specific inquiries; however, access to raw individual-level data will not be provided.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Mar 2028, 25 months after the start.

Of 2,066 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 25 months is above that.

Counting every sponsor, half of 2,243 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2026
First posted
Mar 2, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Mar 31, 2028
CompletionEst.
Jul 31, 2028
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07441655
Lead sponsor
Morehouse School of Medicine
Responsible party
Rakale Collins Quarells (Principal Investigator, Morehouse School of Medicine) — Principal investigator
First posted
Mar 2, 2026
Start date
Feb 1, 2026
Primary completion
Mar 31, 2028 (estimated)
Completion
Jul 31, 2028 (estimated)
Last update
Aug 5, 2026

Study contacts

Asia K Rivers, MPH
Contact
arivers@msm.edu
+1 (404) 752-1610
Rakale C Quarells, PhD
Contact
rquarells@msm.edu
404-752-1956

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion